The China Respiratory Science Development Conference pointed out that chronic respiratory problems, represented by chronic obstructive pulmonary disease (COPD), have become the most prominent and severe public health problem in China, with a prevalence rate of 13.7% among people over 40 years old. According to the "Research Report on the Development Trends and Strategies of the Domestic Oxygen Generator Industry from 2023 to 2028" by China Research Institute of Industry, the demand for precision oxygen therapy in the home oxygen therapy market is continuously increasing.

Weihai Weigao Health Technology Co., Ltd., a subsidiary of Weigao Group, has taken the lead in launching the first automatic oxygen controlled (AOT) oxygen concentrator to meet the precise oxygen therapy needs of patients, leading the industry development and helping medical progress.

01. Innovative automatic oxygen control technology breaks the limitations of constant oxygen production
Traditional oxygen concentrators lack a dynamic adjustment mechanism, making it difficult to adjust oxygen flow based on the patient's actual blood oxygen level. Patients may face the risk of insufficient or excessive oxygen intake. The new oxygen concentrator launched by Weigao Health has successfully included the automatic oxygen flow regulation function in the registration certificate of household oxygen concentrators for the first time, providing patients with safer, more effective, and personalized home oxygen therapy solutions, and promoting the industry towards precision medicine with innovative technology.

The new version of the oxygen therapy guidelines states that different chronic respiratory patients have different target blood oxygen saturation levels. The automatic oxygen control system of the oxygen concentrator can sense the patient's blood oxygen saturation in real time, adjust the appropriate oxygen flow rate, and avoid poor oxygen inhalation effect caused by high or low oxygen flow rate. Research has shown that precision oxygen therapy can significantly reduce breathing difficulties and improve activity endurance in patients with chronic obstructive pulmonary disease (COPD). It has important clinical significance for guiding the rehabilitation treatment and oxygen therapy plan of COPD patients.

02. Focus on precise oxygen therapy and lead industry standardization
As a driving force in the domestic home medical equipment industry, Weigao Health's successful launch of the automatic oxygen controlled oxygen concentrator not only demonstrates its strength in technological innovation and product research and development, but also provides new directions and standards for the development of the entire oxygen concentrator market.

Clinical norms: Based on the "Chinese Guidelines for Home Oxygen Therapy for Adult Respiratory Diseases (2024)" as the research and development basis, the clinical norms and scientificity of the product are ensured, providing standardized oxygen therapy guidance for patients.

Oxygen therapy experience: By intelligently adjusting the oxygen flow rate, on the one hand, it ensures that patients receive just the right amount of oxygen therapy, safely and stably increasing blood oxygen, ensuring the accuracy and effectiveness of oxygen therapy; On the one hand, it reduces the manual operation of patients and their families, improves the convenience and compliance of oxygen therapy, and helps patients to adhere to oxygen therapy for a long time, thereby improving their quality of life.

Relying on the profound accumulation and professional resources of Weigao Group in the field of medical devices, Weigao Health has always adhered to technological innovation and product research and development, promoting the standardized and intelligent development of the home oxygen therapy market. In the future, Weigao Health will continue to increase research and development investment, deepen cooperation with hospitals, and continuously launch products guided by treatment effects, providing more scientific, effective, and personalized home oxygen therapy solutions for patients with chronic obstructive pulmonary disease and more chronic respiratory diseases.

Source: http://qixieke.com/Font/index/detailPage.html?id=3373-145